COMPANY

NEOGEN’S JOURNEY

  • 2024

    • Approved Merger of Buli Chemicals with Neogen Chemicals Limited
    • Neogen Ionics- Wholly owned subsidiary of the Company availed a facility of Rs. 894 crores ($108 million) from SBI.
    • Neogen Chemicals Japan Corporation Limited – the wholly owned subsidiary of the Company incorporated in July 2024.

  • 2023

    • Formed a wholly owned subsidiary of Neogen Chemicals namely Neogen Ionics Limited to house Battery Chemicals Business in March 2023.
    • Acquired 100% stake in BuLi Chem from Livent in May 2023 to offer organolithium products to Pharma and Agrochemical Industries.
    • Raised ~ ₹ 253 crore through allotment of equity shares on preferential basis.
    • Neogen Ionics Ltd. completed acquisition of Land admeasuring ~65 acres in Pakhajan, Dahej PCPIR , Gujarat, to establish a world-class state-of-the-art Battery Materials facility at a Greenfield site.
    • Approved incorporation of a wholly-owned subsidiary in Japan.

  • 2021

    Phase I & II expansion completed:

    • Increased Organic Chemicals reactor capacity from 154,000 litres to 407,000 litres through Greenfield and brownfield expansions across facilities.
    • Raised Rs. 225 crore through allotment of equity shares on preferential basis.

  • 2020

    Increased the capacity for inorganic chemicals from 1,200 MT to 2,400 MT through Greenfield expansion at Dahej, Gujarat

  • 2019

    Raised Rs. 132 crore through initial public offering (IPO) and Offer for Sale

  • 2017

    Commenced manufacturing operations at Vadodara Facility

  • 2016

    • Achieved turnover of ₹100 crore
    • Acquired manufacturing operations along with 39.6 acres of land from Solaris Chemtech Limited at Karakhadi, Vadodara

  • 2015

    Acquired land in Dahej SEZ

  • 2012

    Further increased reactor capacity at Mahape to 45,000 litres

  • 2007

    Increased reactor capacity at Mahape to 30,000 litres

  • 2001

    • Started manufacturing specialty Bromine compounds for advanced intermediates
    • Increased reactor capacity of Mahape facility from 6,000 litres to 20,000 litres

  • 2000

    Set up of dedicated R&D Division

  • 1998

    Converted to public limited company

  • 1994

    Increased in capacity from 1,600 litres to 6,000 litres at Mahape

  • 1991

    Started operations with Lithium salts and organic bromide at Mahape

  • 1989

    Incorporation as a private limited company to scale up existing bromine derivatives business